New blood test study aims to spot ovarian cancer earlier
NCT ID NCT02326064
Summary
This study tested new blood markers and calculation tools to help doctors better tell the difference between benign (non-cancerous) and malignant (cancerous) ovarian tumors before surgery. It involved 221 women who were scheduled for surgery to remove an ovarian cyst that was thought to be benign. The goal was to see if these new methods could lead to earlier and more accurate diagnosis of ovarian cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH de Saint Nazaire
Saint-Nazaire, 44606, France
-
CHD Vendée
La Roche-sur-Yon, 85925, France
-
CHU de Nantes
Nantes, 44093, France
-
Centre Hospitalier de Cholet
Cholet, 49300, France
Conditions
Explore the condition pages connected to this study.